The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Revolutionizing Drug Development: Navigating the Convergence of Artificial Intelligence and Pharmaceutical Innovation
|
|
Author(s): K. S. Giriprasath (PSG Institute of Technology and Applied Research, Coimbatore, India), P. Pandiyarajan (Hindusthan Institute of Technology, Coimbatore, India), C. Santhosh (PSG Institute of Technology and Applied Research, Coimbatore, India), K. Aneesh (Rathinam College of Arts and Science, India)and R. Vasanth (Department of Computing Technologies, School of Computing, College of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu, India)
Copyright: 2024
Pages: 27
Source title:
Analyzing Explainable AI in Healthcare and the Pharmaceutical Industry
Source Author(s)/Editor(s): Veena Grover (Noida Institute of Engineering and Technology, India), Balamurugan Balusamy (Manipal Academy of Higher Education, Dubai, UAE), Nallakaruppan M.K. (Vellore Institute of Technology, India), Vijay Anand (Vellore Institute of Technology, India)and Mariofanna Milanova (University of Arkansas at Little Rock, USA)
DOI: 10.4018/979-8-3693-5468-1.ch009
Purchase
|
Abstract
A disruptive age has begun with the convergence of drug development with artificial intelligence (AI), which has profoundly changed the field's traditional boundaries and potential. This chapter explores the numerous uses of artificial intelligence in the complex network of drug development. Through a thorough examination of the complex interactions between artificial intelligence (AI) and the intricacies of the drug development process, this chapter provides a sophisticated understanding of the difficulties encountered and the new opportunities that have arisen from this mutually beneficial partnership. This chapter provides a thorough description of the opportunities and challenges that are always changing within this quickly developing industry, acting as a compass for navigating the challenges associated in exploiting AI's potential in the field of drug discovery. By setting the foundation for ground-breaking findings, this chapter significantly advances our understanding and the growing integration of AI in the field of drug development.
Related Content
|
Frederic Andres.
© 2027.
14 pages.
|
|
Kalsoom Safdar, Khairul Najmy Abdul Rani, Mohd Aminudin Jamlos, Siti Julia Rosli, Muhammad Usman Younus, Zanab Safdar.
© 2027.
27 pages.
|
|
Bani Adam, Binastya Anggara Sekti, Muhammad Adi Zacky Zahran.
© 2027.
24 pages.
|
|
Swetha Margaret T. A., Renuka Devi D..
© 2027.
31 pages.
|
|
Maurice Saluschke, Michael Schulz.
© 2027.
30 pages.
|
|
Mirjam Sepesy Maučec, Gregor Donaj.
© 2027.
16 pages.
|
|
Jorge A. Ruiz-Vanoye, Ocotlan Diaz-Parra, Ricardo A. Barrera-Cámara, Alejandro Fuentes-Penna, Francisco R. Trejo-Macotela, Jaime Aguilar-Ortiz, Eric Simancas-Acevedo.
© 2027.
21 pages.
|
|
|